Abstract:The application of metabolomics in translational research suffers from several technological bottlenecks, such as data reproducibility issues and the lack of standardization of sample profiling procedures. Here, we report an automated high-throughput metabolite array technology that can rapidly and quantitatively determine 324 metabolites including fatty acids, amino acids, organic acids, carbohydrates, and bile acids. Metabolite identification and quantification is achieved using the Targeted Metabolome Batch Quantification (TMBQ) software, the first cross-vendor data processing pipeline. A test of this metabolite array was performed by analyzing serum samples from patients with chronic liver disease (<i>N</i> = 1234). With high detection efficiency and sensitivity in serum, urine, feces, cell lysates, and liver tissue samples and suitable for different mass spectrometry systems, this metabolite array technology holds great potential for biomarker discovery and high throughput clinical testing. Additionally, data generated from such standardized procedures can be used to generate a clinical metabolomics database suitable for precision medicine in next-generation healthcare.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04686?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04686</a>.MRM transitions of 3-NPH derivatized metabolites, linearity range, precision, and accuracy (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_001.xlsx">XLSX</a>)UPLC-MS/MS instrument settings (Table S2). Clinical information on study subjects (Table S3). Stability of derivatized analytes in biological sample matrices stored under −80 °C (Table S4). Metabolites identified by TargetLynx (Table S5). Metabolites identified by TMBQ (Table S6). The relative differences of levels of metabolites (mean ± S.D.) identified by TMBQ and TargetLynx (Table S7). The Pearson correlation coefficients of the same metabolites quantified by TMBQ and TargetLynx (Table S8). Quantification results in normal human serum, urine, feces, mouse liver and HepG2 cell samples (Median ± SE) (Table S9). Detected metabolites in the control and liver disease patients (Table S10). Effect of the concentration and quantity of the 3-nitrophenylhydrazine on the chemical derivatization (Figure S1). Effect of the concentration and quantity of the EDC on the 3-nitrophenylhydrazine derivatization (Figure S2). Effect of reaction temperature on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S3). Effect of reaction time on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S4). Typical TIC chromatograms of all 320 metabolite standards (Figure S5). Typical EIC of organic acid standards (Figure S6). Typical EIC of carbohydrates (Figure S7). Typical EIC of bile acid standards (Figure S8). Typical EIC of fatty acid standards (Figure S9). Typical EIC of amino acids and nucleotides (Figure S10). Typical EIC of short chain fatty acids (Figure S11). Workflow and main features of TMBQ (Figure S12). Fragmentation pattern of butyric acid in ESI negative mode as an example (Figure S13). The real metabolite assay kit of the metabolite array used for the analysis of samples in this study (Figure S14). OPLS-DA scores plots of serum metabolite profiles of the controls and liver disease patients and Pie chart showing the chemical classification of the detected metabolites in liver disease patients (Figure S15). 3D scores plot of serum metabolite profiles of (A) HBV patients, fibrosis and cirrhosis patients, and (B) HCC and ICC patients (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Metabolite characterisation of the peptide–drug conjugate LN005 in liver S9s by UHPLC-Orbitrap-HRMS

Metabolic Stability and Metabolite Characterization of Capilliposide B and Capilliposide C by LC–QTRAP–MS/MS

Metabolism characterization and toxicity of N-hydap, a marine candidate drug for lung cancer therapy by LC–MS method

Evaluation of the antitumor effects of PP242 in a colon cancer xenograft mouse model using comprehensive metabolomics and lipidomics

Quantification of Antitumor Caffeic Acid-3,4-Dihydroxybenzylethyl Ester and Its Pharmacokinetic Study in Human Liver Microsomes by LC-MS/MS

Isotope labelled in suit derivatization-extraction integrated system for amine/phenol submetabolome analysis based on nanoconfinement effect: Application to lung cancer

Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome

Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model

The use of microwave heating to control insects in cigarette manufacture.

A simple and sensitive liquid chromatography triple quadrupole mass spectrometry method for the determination of XL092 in monkey plasma and its application to pharmacokinetic study

A Metabolite Array Technology for Precision Medicine

Development and validation for bioanalysis of VK2809, its active metabolite VK2809A and glutathione-conjugated metabolite MB06588 in rat liver using LC-MS/MS

A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy

Study on Pharmacokinetics and Metabolic Profiles of Novel Potential PLK-1 Inhibitors by UHPLC-MS/MS Combined with UHPLC-Q-Orbitrap/HRMS

Extensive evaluation of plasma metabolic sample preparation process based on liquid chromatography-mass spectrometry and its application in the in vivo metabolism of Shuang-huang-lian powder injection

A merged method for targeted analysis of amino acids and derivatives using parallel reaction monitoring combined with untargeted profiling by HILIC-Q-Orbitrap HRMS

Cytokine profile and cytotoxicity in response to acute intratracheal dose of Metarhizium anisopliae in BALB/c mice.

A chemical derivatization-based pseudotargeted LC-MS/MS method for high coverage determination of dipeptides

Multidetector CT.

The dynamic metabolic profile of Qi-Yu-San-Long decoction in rat urine using UPLC-QTOF-MSE coupled with a post-targeted screening strategy

Comparison of the Circulating Metabolite Profile of PF-04991532, a Hepatoselective Glucokinase Activator, Across Preclinical Species and Humans: Potential Implications in Metabolites in Safety Testing Assessment